Overview

Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The aims of this study are to investigate whether multimodal treatment of peritoneal carcinomatosis from gastric cancer is feasible and to evaluate the clinical outcomes and clinical effectiveness of neoadjuvant systemic chemotherapy followed by cytoreductive surgery + hyperthermic intraperitoneal chemotherapy + early postoperative intraperitoneal chemotherapy, as compared to systemic chemotherapy only, in patients with peritoneal carcinomatosis from gastric cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Uppsala University
Treatments:
Camptothecin
Cisplatin
Docetaxel
Doxorubicin
Irinotecan
Oxaliplatin
Paclitaxel